Report Detail

Medical Devices & Consumables (Post-pandemic Era)-Global T-Cell Therapy Market Segment Research Report 2022

  • RnM4477547
  • |
  • 04 August, 2022
  • |
  • Global
  • |
  • 105 Pages
  • |
  • XYZResearch
  • |
  • Medical Devices & Consumables

Summary

The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.

2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.

According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.

Beijing Yanjing Bizhi Information Consulting Co., Ltd. (XYZResearch)released the 《(Post-pandemic Era)-Global T-Cell Therapy Market Segment Research Report 2022》, which aims to sort out the development status and trends of the T-Cell Therapy industry at home and abroad, estimate the overall market scale of the T-Cell Therapy industry and the market share of major countries, T-Cell Therapy industry, and study and judge the downstream market demand of T-Cell Therapy through systematic research, Analyze the competition pattern of T-Cell Therapy, so as to help solve the pain points of various stakeholders in T-Cell Therapy industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.

Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of T-Cell Therapy Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in T-Cell Therapy Market?
Gilead Sciences, Inc.
Sorrento Therapeutics
Fate Therapeutics Inc.
Novartis International AG
AbbVie Inc.
Adaptimmune Therapeutics PLC
Bluebird Bio
TCR2 Therapeutics, Inc.
Pfizer Inc.
DiaCarta, Inc.
Major Type of T-Cell Therapy Covered in XYZResearch report:
CAR T Cell Therapy
TCR Therapy
TIL Therapy
Application Segments Covered in XYZResearch Market
Hospitals
Clinics & Ambulatory Centers
Cancer Research Institutes
Others

For any other requirements, please feel free to contact us and we will provide you customized report.


Table of Contents

    Global T-Cell Therapy Market Segment Research Report 2022

      1. Research Scope

        2. Market Overview

        • 2.1 Product Introduction, Application, Picture
        • 2.2 Global T-Cell Therapy Market by Value
          • 2.2.1 Global T-Cell Therapy Revenue by Type
          • 2.2.2 Global T-Cell Therapy Market by Value (%)
        • 2.3 Global T-Cell Therapy Market by Production
          • 2.3.1 Global T-Cell Therapy Production by Type
          • 2.3.2 Global T-Cell Therapy Market by Production (%)

        3. The Major Driver of T-Cell Therapy Industry

        • 3.1 Historical & Forecast Global T-Cell Therapy Demand
        • 3.2 Largest Application for T-Cell Therapy (2018-2028)
        • 3.3 The Major Downstream Company in China Market 2022

        4. Global and Regional T-Cell Therapy Market

        • 4.1 Regional Market Size in Terms of Production & Demand (2022)
        • 4.2 Regional Market Share in Terms of Revenue (2018-2022)
        • 4.3 Concentration Ratio (CR5& CR10) of T-Cell Therapy Market
        • 4.4 Mergers & Acquisitions, Expansion Plans

        5. US T-Cell Therapy Production, Demand (2018-2028)

        • 5.1 Current and Estimated Production Breakdown by Type
        • 5.2 Current and Estimated Demand Breakdown by Type
        • 5.3 Current and Estimated Demand Breakdown by Application
        • 5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        6. Europe T-Cell Therapy Production, Demand (2018-2028)

        • 6.1 Current and Estimated Production Breakdown by Type
        • 6.2 Current and Estimated Demand Breakdown by Type
        • 6.3 Current and Estimated Demand Breakdown by Application
        • 6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        7. China T-Cell Therapy Production, Demand (2018-2028)

        • 7.1 Current and Estimated Production Breakdown by Type
        • 7.2 Current and Estimated Demand Breakdown by Type
        • 7.3 Current and Estimated Demand Breakdown by Application
        • 7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        8. Japan T-Cell Therapy Production, Demand (2018-2028)

        • 8.1 Current and Estimated Production Breakdown by Type
        • 8.2 Current and Estimated Demand Breakdown by Type
        • 8.3 Current and Estimated Demand Breakdown by Application
        • 8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        9. India T-Cell Therapy Production, Demand (2018-2028)

        • 9.1 Current and Estimated Production Breakdown by Type
        • 9.2 Current and Estimated Demand Breakdown by Type
        • 9.3 Current and Estimated Demand Breakdown by Application
        • 9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        10. Korea T-Cell Therapy Production, Demand (2018-2028)

        • 10.1 Current and Estimated Production Breakdown by Type
        • 10.2 Current and Estimated Demand Breakdown by Type
        • 10.3 Current and Estimated Demand Breakdown by Application
        • 10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        11. Southeast Asia T-Cell Therapy Production, Demand (2018-2028)

        • 11.1 Current and Estimated Production Breakdown by Type
        • 11.2 Current and Estimated Demand Breakdown by Type
        • 11.3 Current and Estimated Demand Breakdown by Application
        • 11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
        • 11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)

        12. Global T-Cell Therapy Average Price Trend

        • 12.1 Market Price for Each Type of T-Cell Therapy in US (2018-2022)
        • 12.2 Market Price for Each Type of T-Cell Therapy in Europe (2018-2022)
        • 12.3 Market Price for Each Type of T-Cell Therapy in China (2018-2022)
        • 12.4 Market Price for Each Type of T-Cell Therapy in Japan (2018-2022)
        • 12.5 Market Price for Each Type of T-Cell Therapy in India (2018-2022)
        • 12.6 Market Price for Each Type of T-Cell Therapy in Korea (2018-2022)
        • 12.7 Market Price for Each Type of T-Cell Therapy in Southeast Asia (2018-2022)

        13. Industrial Chain (Impact of COVID-19)

        • 13.1 T-Cell Therapy Industrial Chain Analysis
        • 13.2 Downstream
        • 13.3 Impact of COVID-19
        • 13.4 Post-pandemic Era
        • 13.5 Technology Trends of T-Cell Therapy

        14. T-Cell Therapy Competitive Landscape

        • 14.1 Gilead Sciences, Inc.
          • 14.1.1 Gilead Sciences, Inc. Company Profiles
          • 14.1.2 Gilead Sciences, Inc. Product Introduction
          • 14.1.3 Gilead Sciences, Inc. T-Cell Therapy Sales, Revenue (2018-2022)
          • 14.1.4 Strategic initiatives
        • 14.2 Sorrento Therapeutics
          • 14.2.1 Sorrento Therapeutics Company Profiles
          • 14.2.2 Sorrento Therapeutics Product Introduction
          • 14.2.3 Sorrento Therapeutics T-Cell Therapy Sales, Revenue (2018-2022)
          • 14.2.4 Strategic initiatives
        • 14.3 Fate Therapeutics Inc.
          • 14.3.1 Fate Therapeutics Inc. Company Profiles
          • 14.3.2 Fate Therapeutics Inc. Product Introduction
          • 14.3.3 Fate Therapeutics Inc. T-Cell Therapy Sales, Revenue (2018-2022)
          • 14.3.4 Strategic initiatives
        • 14.4 Novartis International AG
          • 14.4.1 Novartis International AG Company Profiles
          • 14.4.2 Novartis International AG Product Introduction
          • 14.4.3 Novartis International AG T-Cell Therapy Sales, Revenue (2018-2022)
          • 14.4.4 Strategic initiatives
        • 14.5 AbbVie Inc.
          • 14.5.1 AbbVie Inc. Company Profiles
          • 14.5.2 AbbVie Inc. Product Introduction
          • 14.5.3 AbbVie Inc. T-Cell Therapy Sales, Revenue (2018-2022)
          • 14.5.4 Strategic initiatives
        • 14.6 Adaptimmune Therapeutics PLC
          • 14.6.1 Adaptimmune Therapeutics PLC Company Profiles
          • 14.6.2 Adaptimmune Therapeutics PLC Product Introduction
          • 14.6.3 Adaptimmune Therapeutics PLC T-Cell Therapy Sales, Revenue (2018-2022)
          • 14.6.4 Strategic initiatives
        • 14.7 Bluebird Bio
          • 14.7.1 Bluebird Bio Company Profiles
          • 14.7.2 Bluebird Bio Product Introduction
          • 14.7.3 Bluebird Bio T-Cell Therapy Sales, Revenue (2018-2022)
          • 14.7.4 Strategic initiatives
        • 14.8 TCR2 Therapeutics, Inc.
          • 14.8.1 TCR2 Therapeutics, Inc. Company Profiles
          • 14.8.2 TCR2 Therapeutics, Inc. Product Introduction
          • 14.8.3 TCR2 Therapeutics, Inc. T-Cell Therapy Sales, Revenue (2018-2022)
          • 14.8.4 Strategic initiatives
        • 14.9 Pfizer Inc.
          • 14.9.1 Pfizer Inc. Company Profiles
          • 14.9.2 Pfizer Inc. Product Introduction
          • 14.9.3 Pfizer Inc. T-Cell Therapy Sales, Revenue (2018-2022)
          • 14.9.4 Strategic initiatives
        • 14.10 DiaCarta, Inc.
          • 14.10.1 DiaCarta, Inc. Company Profiles
          • 14.10.2 DiaCarta, Inc. Product Introduction
          • 14.10.3 DiaCarta, Inc. T-Cell Therapy Sales, Revenue (2018-2022)
          • 14.10.4 Strategic initiatives

        15. Conclusion

          16. Methodology and Data Source

          Summary:
          Get latest Market Research Reports on T-Cell Therapy. Industry analysis & Market Report on T-Cell Therapy is a syndicated market report, published as (Post-pandemic Era)-Global T-Cell Therapy Market Segment Research Report 2022. It is complete Research Study and Industry Analysis of T-Cell Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

          Last updated on

          REPORT YOU MIGHT BE INTERESTED

          Purchase this Report

          $2,850.00
          $5,700.00
          2,308.50
          4,617.00
          2,676.15
          5,352.30
          441,066.00
          882,132.00
          237,690.00
          475,380.00
          Credit card Logo

          Related Reports


          Reason to Buy

          Request for Sample of this report